Global Minimally Invasive Cosmetic Procedures Market – Forecast till 2027

$4,450$6,250

Clear

Description

Global Minimally Invasive Cosmetic Procedures Market: Information by Products (Hair Removal Lasers, Botulinum Toxins, Microdermabrasion Products), Procedures (Botulinum Toxins, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion), Application (Acne, Trauma Scars, Hyperpigmentation, Adipose Tissue Regeneration), End User (Hospitals, Dermatology Clinics), and Region (North America, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2027

Market Overview
The minimally invasive cosmetic procedures market is estimated to surpass USD 8,400.33 million by 2027 with a significant CAGR of 8.68% during the assessment timeframe. The minimally invasive medical procedure referred to any surgery that is performed through little cuts rather than an enormous opening. Since your specialist will make more modest entry points, one will probably have a speedier recuperation time and less agony than customary open a medical procedure however with similar advantages as a conventional medical procedure. The global market growth is fuelled by the rising acceptance of minimally invasive cosmetic procedures, growing healthcare expenditures and marketing strategies by key players, and the increasing medical tourism industry.
The minimally invasive restorative systems market is fundamentally determined by the expanding interest for minimally invasive cosmetic surgeries in developing countries, the expanding clinical travel industry, rising medical services consumption, and powerful advertising methodologies by central members. The rising number of items dispatches, and endorsements are additionally driving the development of the minimally invasive restorative techniques market. However, troublesome repayment situations and the complexities identified with corrective systems are relied upon to confine the minimally invasive restorative methods market development during the review period.

Segment Overview
The minimally invasive cosmetic procedures market is classified into products, procedures, applications, and end-user.
In terms of products, the minimally invasive cosmetic procedures market is categorized into hair removal lasers, botulinum toxins. The hair removal lasers segment is again divided into Neodymium-doped Yttrium Aluminium Garnet (Nd: YAG) laser, diode lasers, and others.
The botulinum toxins type is again segregated into OnabotulinumtoxinA A, Incobotulinumtoxin A, Rimabotulinumtoxin B, and others.
The other segment deals with micro-needling products, fruit acids, platelet-rich plasma, radiofrequency skin tightening wrinkle removal rejuvenation machine, and cellulite treatment products. In terms of procedures, the minimally invasive cosmetic procedures market is divided into botulinum toxins, soft tissue fillers, chemical peel, laser hair removal, microdermabrasion, and others.
Based on application, the market is subdivided into acne, trauma scars, hyperpigmentation, adipose tissue regeneration, etc. The end-user segment segregates the minimally invasive cosmetic procedures market into hospitals, dermatology clinics, and others.

Regional Analysis
The region-specific analysis of the minimally invasive cosmetic procedures market is spread across North America, Europe, Asia-Pacific, and the Rest of the World.
North America is set to command the global market owing to the largest share of 34.0% in 2020. The region is anticipated to record a notable CAGR of 9.18% during the assessment period. The regional market growth is driven by the increasing demand for cosmetic procedures and the presence of a high number of cosmetic surgeons in North America.
Europe exhibits the second largest market for minimally invasive cosmetic surgeries during the review period followed by Asia- Pacific.

Major players
The major players of the global minimally invasive cosmetics procedures are AbbVie Inc. (US), The Procter & Gamble Company (US), Koninklijke Philips N.V.(Netherlands), Altair Instruments (US), Silhouet-Tone Corporation (Canada), Advanced Microderm Inc. (US), Dermaglow(US), New Shining Image LLC (US), Lasertec Medical Services (Ireland), and Cutera, Inc. (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING ADOPTION OF MINIMALLY INVASIVE COSMETIC PROCEDURES

4.2.2 RISING HEALTHCARE EXPENDITURE AND MARKETING STRATEGIES BY KEY PLAYERS

4.2.3 GROWING MEDICAL TOURISM INDUSTRY

4.3 RESTRAINTS

4.3.1 LACK OF REGULATION IN COSMETIC PROCEDURES

4.3.2 CLINICAL RISKS AND COMPLICATIONS RELATED TO COSMETIC PROCEDURES

4.4 OPPORTUNITY

4.4.1 GROWING ADOPTION OF MINIMALLY INVASIVE COSMETIC PROCEDURES IN EMERGING ECONOMIES

4.5 COVID-19 IMPACT ANALYSIS

4.5.1 IMPACT ON GDP GROWTH

4.5.2 IMPACT ON SUPPLY CHAIN

4.5.3 IMPACT ON DEMAND AND SUPPLY

4.5.4 IMPACT ON REGIONS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES ANALYSIS

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

6 GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET, BY PRODUCTS

6.1 OVERVIEW

6.2 HAIR REMOVAL LASERS

6.2.1 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND: YAG) LASER

6.2.2 DIODE LASERS

6.2.3 OTHERS

6.3 BOTULINUM TOXINS

6.3.1 ONABOTULINUMTOXIN A

6.3.2 INCOBOTULINUMTOXIN A

6.3.3 RIMABOTULINUMTOXIN B

6.3.4 OTHERS

6.4 MICRODERMABRASION PRODUCTS

6.4.1 MICRODERMABRASION TIP

6.4.2 MICRODERMABRASION CRYSTALS

6.4.2.1 ALUMINUM OXIDE CRYSTALS

6.4.2.2 SODIUM BICARBONATE CRYSTALS

6.4.2.3 OTHERS (MAGNESIUM OXIDE, SODIUM CHLORIDE, AND OTHERS)

6.4.3 MICRODERMABRASION CREAMS AND SCRUB

6.4.4 OTHERS

6.5 OTHERS

7 GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET, BY PROCEDURES

7.1 OVERVIEW

7.2 BOTULINUM TOXINS

7.3 SOFT TISSUE FILLERS

7.4 CHEMICAL PEEL

7.5 LASER HAIR REMOVAL

7.6 MICRODERMABRASION

7.7 OTHERS

8 GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 ACNE

8.3 TRAUMA SCARS

8.4 HYPERPIGMENTATION

8.5 ADIPOSE TISSUE REGENRATION

8.6 OTHERS

9 GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 DERMATOLOGY CLINICS

9.4 OTHERS

10 GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 JAPAN

10.4.3 INDIA

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURE MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MINIMALLY INVASIVE COSMETIC PROCEDURE MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11.6.2 MERGER/ACQUISITION

11.6.3 PARTNERSHIP/AGREEMENT

11.7 MAJOR PLAYERS FINANCIAL MATRIX

11.7.1 SALES

11.7.2 R&D EXPENDITURE

12 COMPANY PROFILES

12.1 ABBVIE INC.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 THE PROCTER & GAMBLE COMPANY

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 KONINKLIJKE PHILIPS NV

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 ALTAIR INSTRUMENTS

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 SILHOUET-TONE CORPORATION

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 ADVANCED MICRODERM, INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 DERMAGLOW

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 NEW SHINING IMAGE LLC

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 LASERTEC MEDICAL SERVICES

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 CUTERA

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS